The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.

Gain 2x leveraged exposure to HIMS with HIMZ, ideal for high-risk traders. Read more on how to navigate recent volatility and ...

Lizzo opened up about her relationship with music in a new 'Rolling Stone' interview, touching on how she experienced "very ...

A woman was killed by Baltimore Police during a behavioral crisis call, leaving a neighborhood in mourning and a family ...

A mother has shared her heartbreak at her daughter’s spiral into anxiety aged just six, refusing school and food amid a ...

On her new song “Broken Glass,” from her fourth album 'Virgin,' Lorde gets candid about her struggles with an eating disorder ...

Women’s plus-size apparel retailer Torrid Holdings (NYSE:CURV) fell by 36.4% on Wednesday after the company announced a ...

Interior Health's CEO is stepping down amid the ongoing pediatrics ward closure and rising tide of criticism about her ...

By the age of nine, she had already endured multiple forms of abuse. So when she discovered her Instagram account had been ...

Alabama native Lisa Roberts, 65, had been navigating depression for most of her adult life. Roberts, who works in ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Breanna T., an ER nurse, suddenly lost her vision while at work and documented the terrifying five-day journey to a diagnosis ...